Intravenous immunoglobulin therapy in a child with cutaneous polyarteritis nodosa

Clinical and Experimental Rheumatology

Volumn 16, Issue 2, 1998, Pages 187-189

  Uziel, Y ^a,b,c   Silverman, E D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Hospital for Sick Children

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Children; Cutaneous polyarteritis nodosa (CPAN); Intravenous immunoglobulin (IVIG)

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ARTICLE; CANADA; CASE REPORT; CORTICOSTEROID THERAPY; HUMAN; MALE; PATHOGENESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; POLYARTERITIS NODOSA; SKIN;

EID: 0031799291     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. FINK CW: The role of the streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa.J Rheumatol 1991; 18 (Suppl. 29): 14-20.
2. DAVID J, ANSELL BM, WOO P: Polyarteritis nodosa associated with streptococcus. Arch Dis Child 1993; 69: 685-8.
3. SIBERRY GK, COHEN BA, JOHNSON B: Cutaneous polyarteritis nodosa. Report of two cases in children and review of the literature. Arch Dermatol 1994; 130 (7): 884-9.
4. KUMAR L, THAPA BR, SARKAR B, WALIA BN: Benign cutaneous polyarteritis nodosa in children below 10 years of age -A clinical experience. Ann Rheum Dis 1995; 54: 134-6.
5. IMBACH P, BARANDUN S, D'APUZZO V et al.: High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; i: 1228-31.
6. NEWBURGER JW, TAKAHASHI M, BURNS JC et al.: The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986; 315: 341-7.
7. DALAKAS MC. ILLA I, DAMBROSIA JM: A controlled trial of high dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993; 329: 1993-2000.
8. LEVINSON AI: The use of IVIG in neurological disease. In: BALLOW M et al. (Eds.): IVIG Therapy Today. Totawa NJ, Humana Press, 1992; 93-104.
9. JORIZZO JL, WHITE WL, WISE CM, ZANOLLI MD, SHERERTZ EF: Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: Cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol 1991; 24 (6 Pt. 1): 973-8.
10. CALDERON MJ, LANDA N, AGUIRRE A, DIAZ-PEREZ JL: Successful treatment of cutaneous PAN with pentoxifylline. Br J Dermatol 1993; 128: 706-8.
11. UZIEL Y, LAXER R, SCHNEIDER R, SILVERMAN E: Intravenous immunoglobulin therapy in systemic juvenile rheumatoid arthritis. A follow up study. J Rheumatol 1996; 23: 910-8.
12. SILVERMAN ED, CAWKWELL GD, LOVELL JD, et al.: Intravenous immune globulin in the treatment of systemic JRA. A randomized placebo controlled trial. J Rheumatol 1994; 21: 2353-8.
13. ODA H, HONDA H, SUGITA K, NAKAMURA A, NAKAJIMA H: High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evan's syndrome). J Pediatr 1985; 107: 744-6.
14. KNOFLACH P, MULLER C, EIBL MM: Crohn's disease and intravenous immunoglobulin G. Ann Intern Med 1990; 112: 285-6.
15. GODARD W, ROUJEAU JC, GUILLOT B, ANDRE C, RIFLE G: Bullous pemphigoid and intravenous gammaglobulin. Ann Intern Med 1985; 103: 965.
16. STURFLET G, MOUSA F, JOHNSSON H, NIVED O, THYSELL H, WOLLHEIM F: Recurrent cerebral infarction and the anti-phospholipid syndrome: Effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus. Ann Rheum Dis 1990; 49: 939-41.
17. TOMER Y, SHOENFELD Y: Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 1992; 10: 391-3.
18. KAVERI SV, DIETRICH G, HUREZ V, KAZATCHKINE MD: Intravenous immunoglobulins (IVIG) in the treatment of autoimmune disease. Clin Exp Immunol 1991; 86: 192-9.